We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Dentsply (XRAY) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Read MoreHide Full Article
For the quarter ended September 2026, Dentsply International (XRAY - Free Report) reported revenue of $836 million, down 7.5% over the same period last year. EPS came in at $0.29, compared to $0.37 in the year-ago quarter.
The reported revenue represents a surprise of -2.34% over the Zacks Consensus Estimate of $855.98 million. With the consensus EPS estimate being $0.30, the EPS surprise was -3.33%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Dentsply performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Net sales- Americas: $319 million versus the three-analyst average estimate of $314.3 million. The reported number represents a year-over-year change of +9.6%.
Net sales- EMEA: $397 million versus $406.57 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +3.9% change.
Net sales- APAC: $120 million compared to the $87.21 million average estimate based on two analysts.
Net sales- Essential Dental Solutions: $343 million versus the five-analyst average estimate of $339.51 million. The reported number represents a year-over-year change of -3.9%.
Net sales- Orthodontic and Implant Solutions: $171 million versus the five-analyst average estimate of $184 million. The reported number represents a year-over-year change of -16.6%.
Net sales- Connected Technology Solutions: $230 million versus the five-analyst average estimate of $246.14 million. The reported number represents a year-over-year change of -11.2%.
Net sales- Wellspect Healthcare: $92 million compared to the $84.86 million average estimate based on five analysts. The reported number represents a change of +10.8% year over year.
Net sales- Orthodontic and Implant Solutions- Implants & Prosthetics: $132 million compared to the $146.21 million average estimate based on two analysts. The reported number represents a change of -13.2% year over year.
Net sales- Connected Technology Solutions- CAD/CAM: $93 million versus $105 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -16.2% change.
Net sales- Connected Technology Solutions- Equipment & Instruments: $137 million compared to the $141.06 million average estimate based on two analysts. The reported number represents a change of -7.4% year over year.
Net sales- Orthodontic and Implant Solutions- Orthodontics: $39 million versus the two-analyst average estimate of $39.91 million. The reported number represents a year-over-year change of -26.4%.
Adjusted Operating Income- Connected Technology Solutions: $-3 million compared to the $12.29 million average estimate based on two analysts.
Shares of Dentsply have returned +24.7% over the past month versus the Zacks S&P 500 composite's -0.4% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
View the Zacks #1 Rank List
Image: Bigstock
Dentsply (XRAY) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
For the quarter ended September 2026, Dentsply International (XRAY - Free Report) reported revenue of $836 million, down 7.5% over the same period last year. EPS came in at $0.29, compared to $0.37 in the year-ago quarter.
The reported revenue represents a surprise of -2.34% over the Zacks Consensus Estimate of $855.98 million. With the consensus EPS estimate being $0.30, the EPS surprise was -3.33%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Dentsply performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:View all Key Company Metrics for Dentsply here>>>
Shares of Dentsply have returned +24.7% over the past month versus the Zacks S&P 500 composite's -0.4% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.